Next |
home / stock / mcrb / mcrb message board
Subject | By | Source | When |
---|---|---|---|
$MCRB Perverse mkt action now. Candidate passed PDUFA | MiamiGent | investorshub | 04/28/2023 5:29:25 PM |
ARNA did that in the past- an offering | MiamiGent | investorshub | 04/28/2023 5:28:18 PM |
Why would they use debt financing rather than | Cosa | investorshub | 04/27/2023 7:48:05 PM |
$MCRB Another comment from another forum | MiamiGent | investorshub | 04/27/2023 3:38:53 PM |
. | MiamiGent | investorshub | 04/27/2023 3:19:40 PM |
. | MiamiGent | investorshub | 04/27/2023 3:19:00 PM |
$MCRB Reprinted from another forum | MiamiGent | investorshub | 04/27/2023 3:17:50 PM |
$MCRB Good morning all. | MiamiGent | investorshub | 04/27/2023 2:09:57 PM |
$MCRB We are #2 Trending, after META. | MiamiGent | investorshub | 04/27/2023 2:35:43 AM |
$MCRB Seres Therapeutics Inc | MiamiGent | investorshub | 04/26/2023 11:34:49 PM |
$MCRB I think we'll see some lift tomorrow. | MiamiGent | investorshub | 04/26/2023 11:01:30 PM |
US FDA approves Seres Therapeutics' pill for deadly | MiamiGent | investorshub | 04/26/2023 10:50:11 PM |
I though it would have a greater immediate | Cosa | investorshub | 04/26/2023 10:32:05 PM |
$MCRB Ok, news out. It passed! | MiamiGent | investorshub | 04/26/2023 10:23:39 PM |
$MCRB Quote | MiamiGent | investorshub | 04/26/2023 7:20:01 PM |
$MCRB PDUFA today | MiamiGent | investorshub | 04/26/2023 12:57:08 PM |
$MCRB countdown to tomorrow's PDUFA. Have you loaded? | MiamiGent | investorshub | 04/25/2023 1:57:37 PM |
$MCRB Wednesday PDUFA | MiamiGent | investorshub | 04/23/2023 11:14:45 PM |
MCRB In today for PDUFA next week. | MiamiGent | investorshub | 04/21/2023 8:23:45 PM |
========================= | Extremist223 | investorshub | 08/08/2022 7:16:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
Transaction supports further development of SER-155, following recent promising clinical data, and other cultivated live biotherapeutics, for multiple medically vulnerable patient populations at high risk of life-threatening bacterial infections Cash received at completion, along with a...
CAMBRIDGE, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that its stockholders voted to approve the previously announced proposed sale of the C...
CAMBRIDGE, Mass., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that the Company, will participate in the Cantor Global Healthcare Conference and Eric Shaff, President and Chief Executive Officer, will represent...